Dr Ashok P Makadia, MD | |
3600 Kolbe Rd Ste 227, Lorain, OH 44053-1601 | |
(440) 960-6431 | |
(440) 960-6435 |
Full Name | Dr Ashok P Makadia |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 33 Years |
Location | 3600 Kolbe Rd Ste 227, Lorain, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013912211 | NPI | - | NPPES |
2204484 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 35078447 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Regional Medical Center | Lorain, OH | Hospital |
Mercy Allen Hospital | Oberlin, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mercy Health Physicians Lorain Specialty Care Llc | 4688070055 | 119 |
News Archive
The malaria parasite molecules associated with severe disease and death-those that allow the parasite to escape recognition by the immune system-have been shown to share key gene segments with chimp and gorilla malaria parasites, which are separated by several millions of years, according to a new study led by Harvard T.H. Chan School of Public Health.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.
Taking statins or being even modestly physically fit markedly improves survival in people with dyslipidaemia (abnormal levels of harmful blood fats/cholesterol), according to new research published Online First in The Lancet. But combining statin treatment with better fitness may do more to ward off death than either intervention alone.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.
› Verified 5 days ago
Entity Name | Mercy Health Physicians Lorain Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023347192 PECOS PAC ID: 1355474172 Enrollment ID: O20100730000651 |
News Archive
The malaria parasite molecules associated with severe disease and death-those that allow the parasite to escape recognition by the immune system-have been shown to share key gene segments with chimp and gorilla malaria parasites, which are separated by several millions of years, according to a new study led by Harvard T.H. Chan School of Public Health.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.
Taking statins or being even modestly physically fit markedly improves survival in people with dyslipidaemia (abnormal levels of harmful blood fats/cholesterol), according to new research published Online First in The Lancet. But combining statin treatment with better fitness may do more to ward off death than either intervention alone.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.
› Verified 5 days ago
Entity Name | Mercy Health Physicians Lorain Specialty Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972126381 PECOS PAC ID: 4688070055 Enrollment ID: O20210909003432 |
News Archive
The malaria parasite molecules associated with severe disease and death-those that allow the parasite to escape recognition by the immune system-have been shown to share key gene segments with chimp and gorilla malaria parasites, which are separated by several millions of years, according to a new study led by Harvard T.H. Chan School of Public Health.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.
Taking statins or being even modestly physically fit markedly improves survival in people with dyslipidaemia (abnormal levels of harmful blood fats/cholesterol), according to new research published Online First in The Lancet. But combining statin treatment with better fitness may do more to ward off death than either intervention alone.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ashok P Makadia, MD 3600 Kolbe Rd Ste 227, Lorain, OH 44053-1601 Ph: (440) 960-6431 | Dr Ashok P Makadia, MD 3600 Kolbe Rd Ste 227, Lorain, OH 44053-1601 Ph: (440) 960-6431 |
News Archive
The malaria parasite molecules associated with severe disease and death-those that allow the parasite to escape recognition by the immune system-have been shown to share key gene segments with chimp and gorilla malaria parasites, which are separated by several millions of years, according to a new study led by Harvard T.H. Chan School of Public Health.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.
Taking statins or being even modestly physically fit markedly improves survival in people with dyslipidaemia (abnormal levels of harmful blood fats/cholesterol), according to new research published Online First in The Lancet. But combining statin treatment with better fitness may do more to ward off death than either intervention alone.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.
› Verified 5 days ago
Patricia E Radigan, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 205 W 20th St, Lorain, OH 44052 Phone: 440-244-3833 Fax: 440-244-5328 | |
Shelley Annetteq Burke, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Lorain Community Hospital, 3700 Kolbe Road, Lorain, OH 44053 Phone: 440-960-4000 | |
Piara L Arora, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3600 Kolbe Rd, Ste 227, Lorain, OH 44053 Phone: 440-960-3304 Fax: 440-960-3482 | |
Dr. Theodore Raymond Pacheco, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3600 Kolbe Rd, Suite 127, Lorain, OH 44053 Phone: 440-414-9200 Fax: 216-201-5582 | |
Dr. John William Schaeffer, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3600 Kolbe Rd, Suite 127, Lorain, OH 44053 Phone: 440-414-9200 Fax: 216-201-5582 | |
Srinivasa R Kunam, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-960-4000 |